STENOCARE A/S (Stenocare) announced October 14, 2022, that it had received approval to supply a new CBD 20 mg/mL medical cannabis oil product to the Danish Pilot Programme. With this new product, Stenocare is the only supplier of CBD oil products under the Pilot Programme and the new products are officially ready for sales across the entire country. Sales can begin:STENOCARE has completed the import of the new medical cannabis oil product into Denmark.

The new product is a CBD oil containing 20 mg/mL with dosing delivered via an oral syringe. The new product is available via pharmacies and requires a prescription from a doctor. Stenocare is the first and so far, only supplier of oil based medical cannabis products for the Danish Pilot Programme with a portfolio of two medical cannabis oil products (ie.

THC30 oil and CBD20 oil) from the GMP certified Canadian supplier, AgMEDICA Bioscience.